SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Apricus Biosciences

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Mirror Image1/14/2016 1:33:13 AM
  Read Replies (3) of 2026
 
This would be what the Sarissa Holdings would look like after today:

1,030,000 Bought at the open market in the 4Q 2014.
5,494,505 Bought at $1.82 in the February 2015 Direct Offering.
1,306,819 Bought today at $0.88. ( * )
6,647,728 Subsequent Closing Shares at $0.88.
( 653,409 ) Warrants issued today and exercisable at 0.88 in 6 months. ( * )
( 3,323,864 ) Warrants that will be issued with the Subsequent Closing Shares at 0.88.
( 2,747,252 ) Warrants that were originally issued at $1.82 and now will be exercisable at 0.88.
____________
7,831,324 Shares that Sarissa owns after today. ( * )
+
6,647,728 Shares that Sarissa will own after Apricus gets Shareholder approval.
6,724,525 Shares that they will own when they exercise the warrants in their entirety. ( * )
_____________

21,203,577 Shares owned after fully exercising warrants and Subsequent Closing. ( * )

(* ) Had to adjust figures after looking at all the documents.

I believe that there are about 83,900,000 Shares Fully Diluted after it's all said and done. And that includes warrants that are way out of the money.

As of right now, we have 52,942,892 Shares Outstanding. And Sarissa owns 7,831,324 of those shares. That is a little under 15% + of the total shares outstanding. No warrants included!

____________________________________________________________________

The reason I had to adjust is because 3 investors participated today. Sarissa Capital, Bank Julius Baer & Co. and Aspire Capital and I allocated the numbers in the wrong column ( I know - Big mistake in the numbers world ).

_____________________________________________________________________

Aspire Capital added 795,455 shares to their holdings in Apricus. And they also hold 397,727 warrants exercisable at .088 in six months. On top of that the company has authorized 1,761,364 shares to be sold in a subsequent transaction, together with 880,682 warrants, all exercisable at .88 each.
That's a total of 3,835,228 shares if fully exercised. The 397,727 shares bought today would add immediately to whatever amount of shares they had prior to this transaction. The last date that Aspire reported their Apricus Holdings was February 13, 2015 and they had 2,267,000 shares back then.

Bank Julius Baer bought 426,137 shares today. There will be a subsequent closing ( with shareholder approval ) of 426,137 more shares and a total of 426,137 warrants between both closings, all exercisable at .88 . I don't know if they still hold the shares they bought back in February 2015.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext